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Abstract
Introduction:  Obstructive  sleep  apnea  syndrome  is  currently  a  public  health  problem  of  great
importance.  When  misdiagnosed  or  improperly  treated,  it  can  lead  to  serious  consequences  on
patients’ quality  of  life.  The  gold  standard  treatment  for  cases  of  obstructive  sleep  apnea
syndrome,  especially  in  mild  to  severe  and  symptomatic  cases,  is  continuous  positive  air-
way pressure  therapy.  Compliance  with  continuous  positive  airway  pressure  therapy  is  directly
dependent on  the  active  participation  of  the  patient,  which  can  be  inﬂuenced  by  several  factors.
Objective:  The  objective  of  this  study  is  to  describe  the  factors  related  to  compliance  with
continuous  positive  airway  pressure  therapy,  and  to  analyze  which  associated  factors  directly
inﬂuence the  efﬁciency  of  the  treatment.
Methods:  Patients  who  received  continuous  positive  airway  pressure  therapy  through  the  Munic-
ipal Health  Department  of  the  city  of  Ribeirão  Preto  were  recruited.  A  structured  questionnaire
was administered  to  the  patients.  Compliance  with  continuous  positive  airway  pressure  therapy
was assessed  by  average  hours  of  continuous  positive  airway  pressure  therapy  usage  per  night.
Patients  with  good  compliance  (patients  using  continuous  positive  airway  pressure  therapy
≥4 h/night)  were  compared  to  those  with  poor  compliance  (patients  using  <4  h/night).
Results: 138  patients  were  analyzed:  77  (55.8%)  were  considered  compliant  while  61  (44.2%)
were non-compliant.  The  comparison  between  the  two  groups  showed  that  regular  monitoring
by a  specialist  considerably  improved  compliance  with  continuous  positive  airway  pressure
therapy  (odds  ratio,  OR  =  2.62). Please cite this article as: Pelosi LB, Silveira ML, Eckeli AL, Chayamiti EM, Almeida LA, Sander HH, et al. The importance of clinical
monitoring for compliance with CPAP. Braz J Otorhinolaryngol. 2016. http://dx.doi.org/10.1016/j.bjorl.2016.05.013
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Conclusion:  Compliance  with  continuous  positive  airway  pressure  therapy  is  related  to  educa-
tional components,  which  can  be  enhanced  with  continuous  and  individualized  care  to  patients
with obstructive  sleep  apnea  syndrome.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Published
by Elsevier  Editora  Ltda.  This  is  an  open  access  article  under  the  CC  BY  license  (http://
creativecommons.org/licenses/by/4.0/).
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A  importância  do  seguimento  clínico  para  adesão  ao  CPAP
Resumo
Introduc¸ão: Síndrome  da  apneia  obstrutiva  do  sono  (SAOS)  é,  atualmente,  um  problema  de
saúde pública  de  suma  importância.  Quando  mal  diagnosticado  ou  tratado  inadequadamente,
pode levar  a  sérias  consequências  na  qualidade  de  vida  do  paciente.  O  tratamento  padrão  ouro
para casos  de  SAOS,  principalmente  nos  casos  moderados  a  grave  e  sintomáticos,  é  o  CPAP
(Continuous  Positive  Airway  Pressure).  A  adesão  ao  CPAP  depende  diretamente  da  participac¸ão
ativa do  paciente,  que  pode  ser  inﬂuenciada  por  vários  fatores.
Objetivo:  O  objetivo  deste  estudo  é  descrever  os  fatores  relacionados  à  adesão  ao  CPAP,  e
analisar quais  fatores  associados  inﬂuenciam  diretamente  na  eﬁciência  do  tratamento.
Método:  Foram  recrutados  pacientes  que  receberam  CPAP  pela  Secretaria  Municipal  de  Saúde
de Ribeirão  Preto.  Um  questionário  estruturado  foi  aplicado  ao  paciente.  A  adesão  ao  CPAP  foi
avaliada pela  média  de  horas  de  uso  do  CPAP  por  noite.  Pacientes  com  boa  adesão  (pacientes
em uso  de  CPAP  ≥4  horas/noite)  foram  comparados  aos  com  má  adesão  (pacientes  em  uso  <4
horas/noite).
Resultados: No  estudo,  138  pacientes  foram  analisados:  77  (55,8%)  foram  considerados  ader-
entes e  61  (44,2%)  foram  não  aderentes.  A  comparac¸ão  entre  os  dois  grupos  demonstrou  que
o seguimento  regular  com  especialista  melhorou  consideravelmente  a  adesão  ao  CPAP  (Odds
Ratio, OR  =  2,62).
Conclusão:  A  adesão  ao  CPAP  está  relacionada  a  componentes  educacionais,  que  podem  ser
aprimorados  com  assistência  contínua  e  individualizada  ao  paciente  com  SAOS.
© 2016  Associac¸a˜o  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Ce´rvico-Facial.  Publicado
por Elsevier  Editora  Ltda.  Este e´  um  artigo  Open  Access  sob  uma  licenc¸a  CC  BY  (http://
creativecommons.org/licenses/by/4.0/).
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he  Obstructive  Sleep  Apnea  Syndrome  (OSAS)  is  now  con-
idered  a  major  public  health  problem,  with  a  prevalence,
espectively,  of  4%  and  2%  in  males  and  females.1 In  a  recent
pidemiological  study  conducted  in  the  city  of  São  Paulo,
he  prevalence  of  OSAS  among  adults  was  32.8%.2 In  undiag-
osed  or  untreated  cases,  OSAS  can  lead  to  signiﬁcant  and
ermanent  impact  on  the  quality  of  life  of  patients,  reducing
verall  cognitive  function.3 In  addition,  OSAS  is  related  to  a
igh  rate  of  morbidity  and  mortality,  and  is  associated  with
iseases  such  as  systemic  hypertension,4 acute  myocardial
nfarction  and  ischemic  stroke.
The  pathophysiology  of  OSAS  involves  the  upper  airways
uring  sleep.  The  main  associated  factors  are  anatomic
bstructive  factors  (such  as  adenotonsillar  hypertrophy,
ase  of  tongue  hypertrophy  and  neck  masses),  neuromus-
ular  changes,  fat  distribution  in  the  cervical  region,5 or  an
ssociation  of  these  conditions.
The  gold  standard  treatment  for  OSAS,  especially  in
ild  to  severe  and  symptomatic  cases,  is  CPAP  (Continu-
us  Positive  Airway  Pressure).6 CPAP  is  a  non-invasive,7 easy
o  use  and  highly  effective  treatment.  When  well  suited
o  this  treatment,  the  compliant  patient  shows  signiﬁcant
C
fmprovement  in  quality  of  life,  with  reduction  of  daytime
leepiness  and8 reduction  of  cardiovascular  risk.8,9 How-
ver,  this  beneﬁt  does  not  occur  if  the  patient  does  not
dhere  to  treatment.  Thus,  compliance  with  treatment
s  an  important  negative  impasse  in  the  management  of
SAS,  and  directly  depends  on  the  involvement  of  the
atient.7
According  to  the  literature,  several  characteristics  can
nﬂuence  compliance  with  CPAP:  other  health  problems  in
ddition  to  OSA,  the  availability  of  polysomnography  to
itrate  the  pressure  to  be  ideally  used  in  CPAP  and  psychoso-
ial  and  economic  factors.10
A  few  years  ago,  an  agreement  between  the  Secretaria
e  Saúde  de  Ribeirão  Preto  and  the  Hospital  das  Clínicas  da
aculdade  de  Medicina  de  Ribeirão  Preto  (HCFMRP)  --  Uni-
ersidade  de  São  Paulo  optimized  access  to  CPAP  among
itizens.  Once  the  equipment  had  been  prescribed  by  the
pecialist,  the  Health  Department  provided  the  CPAP  to
atients  free  of  charge.  Thus,  the  economic  problem,  a
articularly  important  obstacle  in  developing  countries,  has
een  eliminated.11
The  aim  of  this  study  was  to  observe  the  compliance  with
PAP  in  those  patients  and  to  analyze  the  possible  related
actors.
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asthma,  and  GERD,  and  the  habits  of  smoking  and  alcohol
consumption  (Table  2).  Although  there  was  no  difference  in
prevalence  between  the  groups,  patients  with  depression
use  signiﬁcantly  fewer  hours  of  CPAP  than  those  without
Table  1  Comparison  of  demographic  data  between
patients  in  Group  1  (good  adherence  to  CPAP)  and  of  Group
2 (poor  adherence  to  CPAP),  through  Student’s  t  test.
Parameter
(average  ±  SD)
Group  1  Group  2  p
Age  57.84  ±  1.36  58.67  ±  1.28  0.65
BMI 32.88  ±  0.66  33.48  ±  0.89  0.59
AHI at  diagnosis  47.6  ±  4.10  40.52  ±  3.92  0.21ARTICLE
Importance  of  clinical  monitoring  for  compliance  
Methods
Patients  who  received  CPAP  from  Secretaria  Municipal  de
Ribeirão  Preto  were  invited  to  participate  in  the  study.  They
were  instructed  to  attend  the  Ambulatório  dos  Distúrbios  do
Sono  do  HCFMRP,  bringing  CPAP  equipment  with  them.
Participants  who  attended  the  invitation  responded  to
a  pre-established  questionnaire  addressing  age,  associated
diseases  such  as  depression,  systemic  arterial  hyperten-
sion  (SAH),  diabetes,  hypothyroidism,  acute  myocardial
infarction  (AMI),  ischemic  stroke  (stroke),  asthma  and  gas-
troesophageal  reﬂux  (GERD),  smoking,  drinking,  and  drugs
in  use.  The  historical  time  of  diagnosis  of  OSAS  and  CPAP
use  (in  years)  was  recorded,  as  well  as  whether  the  patient
was  using  nasal  or  face  mask.  Finally,  whether  the  patient
was  followed  up  in  public  or  private  health  service  was
recorded.
In  addition,  patients  were  asked  about  what  they  knew
about  their  disease  (OSAS),  through  two  questions:  (a)  ‘‘Do
you  know  what  disease  you  have  that  is  treated  with  CPAP?’’;
(b)  ‘‘Do  you  know  what  possible  complications  occur  if  the
OSAS  is  not  treated  properly?’’.  The  degree  of  satisfaction
with  treatment  was  approached  by  the  question:  ‘‘How  sat-
isﬁed  are  you  with  your  treatment?’’  Daytime  sleepiness  was
evaluated  by  the  Epworth  Sleepiness  Scale  (ESS).12,13
The  patients  were  then  submitted  to  the  general  and
ENT  physical  examination.  The  following  components  were
recorded:  body  mass  index  (BMI),  neck  circumference,
rhinoscopy  (with  observations  of  any  septal  deviation  and
characteristics  of  the  nasal  conchae)  and  oroscopy  (with
grading  of  tonsils,  palate  and  tongue,  respectively,  by  Brod-
sky,  Mallampati  and  Friedman  Classiﬁcations).14 The  results
of  diagnostic  polysomnography  were  also  recorded,  when
available.
Compliance  with  CPAP  was  determined  by  averaging  of
hours  of  use  per  night,  identiﬁed  on  the  hour  meter  in  the
equipment.  On  the  equipment  that  already  provided  the
average  per  night,  this  information  was  recorded.  On  the
equipment  that  had  only  the  information  of  hours  of  use,
the  number  was  recorded  and  the  patient  appeared  in  a new
return,  on  average  one  to  two  months  after  the  ﬁrst  visit,
for  a  new  record  of  the  hour  meter  and  calculation  of  aver-
age  per  night.  Additionally,  the  pressure  used  in  the  CPAP
(cm/H2O)  was  recorded.
Patients  were  divided  into  two  groups:  Group  1  --  patients
with  good  compliance  with  CPAP  (mean  CPAP  use  >4  h  per
night);  and  Group  2  --  those  with  inadequate  compliance
(mean  CPAP  use  <4  h  per  night).15 After  identifying  the
fact  that  the  patient  was  not  in  proper  use  of  equipment,
patients  in  Group  2  received  guidance  on  the  importance
of  its  optimal  use,  and  those  with  no  monitoring  were  told
to  return  to  the  institution/clinic  where  the  equipment  was
provided.  Patients  with  incomplete  data  were  excluded.
The  comparison  between  the  two  groups  was  performed
through  the  following  tests:
Fisher’s  exact  test  to  compare  frequency  data  such  as:
gender,  associated  diseases,  type  of  service  where  he/she
was  being  monitored  (public  or  private),  type  of  mask
used  and  information  on  knowledge  or  clinical  monitoring;
Unpaired  Student’s  t  test  was  used  to  compare  the  data:
age,  hours  of  use  of  CPAP,  Apnea  and  Hypopnea  Index  (AHI),
BMI,  ESS  and  years  of  diagnosis  of  OSA  and  use  of  CPAP. PRESS
3
Finally,  the  number  of  hours  of  use  of  CPAP  was  cor-
elated  with  the  parameters  of  BMI,  age,  AHI,  pressure
sed  in  CPAP  and  ESS.  For  this  purpose,  Pearson  correlation
est  was  used.  For  all  statistical  analyzes,  the  differences
ere  considered  signiﬁcant  at  p  <  0.05.  The  project  was
pproved  by  the  local  Ethics  Research  Committee  with  num-
er  06340012.0.0000.5440.
esults
ne  hundred  and  eighty  patients  attended  the  consultation;
f  these,  for  75  patients  a  single  visit  was  enough  to  get  the
verage  of  hours  of  CPAP  use;  for  the  other  105  patients,  the
econd  consultation  was  necessary  to  obtain  this  informa-
ion.  Of  these,  42  were  excluded  because  they  did  not  attend
 return  visit.  Thus,  138  patients  completed  all  phases  of  the
tudy,  including  63  (45.6%)  women  and  75  (54.4%)  men.  The
ean  age  (±standard  deviation)  was  58.20  ±  11.02  years  and
he  mean  BMI  (±standard  deviation)  33.19  ±  6.20  kg/m2.
AHI  data  was  obtained  from  83  patients,  with  the  mean
alue  being  45.52  ±  26.56.  Twenty-seven  of  these  patients
ad  moderate  OSA  and  comorbidities,  while  56  had  severe
SA.  Overall,  the  associated  diseases  were  present  at  the
ollowing  frequencies:  hypertension  in  87  patients;  DM  in
9;  depression  in  31;  hypothyroidism  in  18;  asthma  in  13;  and
ERD  in  19  patients.  Five  patients  had  a  history  of  previous
yocardial  infarction  or  stroke.  Thirty-seven  were  or  had
een  smokers,  while  13  had  alcohol  abuse  history.
In  general,  the  percentage  of  patients  receiving  CPAP
nd  who  had  compliance  considered  adequate  was  55.8%.
eventy-seven  patients  formed  Group  1  (good  compliance
ith  CPAP)  and  61  Group  2  (poor  compliance  with  CPAP).  The
verage  hours  of  CPAP  use  in  Group  1  was  6.13  ±  0.15  h,  and
n  Group  2  of  1.05  ±  0.17  h.  The  mean  difference  among  the
roups  was  5  h,  which  was  signiﬁcantly  statistic  (p  <  0.0001,
5%  CI  4.63--5.53).
The  comparison  of  demographics  between  the  two  groups
as  not  signiﬁcant,  either  for  age,  BMI  or  AHI  diagnosis
Table  1).  In  83  patients  who  had  information  of  AHI,  the
orrelation  between  AHI  and  the  number  of  hours  of  use
as  not  signiﬁcant  (r  =  0.18;  95%  CI  −0.03  to  0.38;  p  =  0.09).
There  was  also  no  signiﬁcant  difference  between
he  groups  for  gender,  presence  of  hypertension,  DM,
epression,  hypothyroidism,  myocardial  infarction,  stroke,AHI, apnea and hypopnea index; BMI, body mass index; SD,
standard deviation.
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Table  2  Comparison  of  demographic  data  and  frequency
of associated  diseases  between  Group  1  (patients  with  good
adherence  to  CPAP)  and  Group  2  (patients  with  poor  adher-
ence to  CPAP),  through  Fisher’s  exact  test.
Parameter  Group  1  (%)  Group  2  (%)  p
Gender  54.5  45.9  NS
SH 62.3 63.9 NS
DM 29.8 26.2 NS
Depression  18.2 27.4 NS
Hypothyroidism  14.3  11.4  NS
Previous  AMI/stroke  2.6  4.9  NS
Asthma  9.0  9.8  NS
GERD 9.0  9.8  NS
Smoking  24.6  29.5  NS
Alcohol  abuse  10.3  8.2  NS
SH, systemic hypertension; DM, diabetes mellitus; AMI, acute
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Figure  2  Correlation  between  average  hours  of  CPAP  use  and
Epworth  Sleepiness  Scale  on  patients  analyzed.  Study  with  Pear-
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epression  (4.05  ±  0.27  vs.  2.24  ±  0.33;  p  <  0.0001).  The  dif-
erence  persists  being  not  signiﬁcant  for  other  diseases.
Knowledge  of  the  disease,  its  implications  and  possi-
le  complications  were  statistically  different  between  the
roups.  Among  patients  in  Group  1,  56  of  77  (72.7%)  showed
dequate  knowledge  of  OSAS,  while  only  34  of  61  (55.7%)  in
roup  2  mentioned  it  (p  <  0.05;  95%  CI  0.99--2.03).  Having
dequate  knowledge  about  the  disease  increased  compli-
nce  with  CPAP,  with  odds  ratio  (OR)  of  1.42.
Complaints  about  adherence  were  reported  by  44  of
he  61  patients  in  Group  2  and  38  of  the  77  patients  in
roup  1  (p  <  0.01;  95%  CI  0.49--0.89).  Although  CPAP  medium
ressure  was  not  signiﬁcantly  different  between  groups
mean  CPAP  pressure  of  8.95  ±  0.34  cm/H2O  for  Group  1  vs.
.46  ±  0.27  cm/H2O  for  Group  2,  p  =  0.25;  95%  CI  0.36--1.38),
he  number  of  hours  of  CPAP  use  is  positively  correlated  to
ts  average  pressure  (r  =  0.04;  p  <  0.05),  suggesting  that  the
igher  the  pressure,  the  more  compliant  the  patient  will  be
ith  treatment  (Fig.  1).
The  time  of  diagnosis  and  CPAP  use  did  not  inﬂuence
ompliance:  patients  from  Group  1  had  a  diagnosis  of  OSAS
or  a  period  of  3.56  ±  0.32  years,  while  those  from  Group  2
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ere  diagnosed  3.53  ±  0.29  years  (p  =  0.94)  before.  Patients
rom  group  1  received  CPAP  and  were  using  it for  an
verage  of  2.90  ±  0.21  years  compared  to  2.91  ±  0.24  years
or  Group  2  (p  =  0.99).
Regular  monitoring  (at  least  every  6  months)  was
eported  by  64  of  77  (83.1%)  patients  of  Group  1,  com-
ared  with  26  of  61  (42.6%)  in  group  2  (p  <  0.0001;  95%  CI
.62--4.25).  Regular  follow-up  with  a  specialist  was  related
o  greater  compliance  with  CPAP,  with  OR  =  2.62.  This  is
specially  important  when  one  considers  that  the  groups
ere  in  CPAP  treatment  for  the  same  period  of  time.
The  compliance  rate  among  patients  who  were  referred
y  the  Private  Medical  Service  was  51.3%  and  in  the  Public
ervice  was  60.6%.  In  this  region,  there  is  only  one  pub-
ic  service  to  follow  these  patients  that  offers  therapy  with
ultidisciplinary  approach  (involving  otolaryngologists,  neu-
ologists,  pulmonologists,  physiotherapists,  nutritionists  and
peech  therapists).  This  could  explain  the  better  result  in
he  Public  Service.  Importantly,  this  difference  was  not  sta-
istically  signiﬁcant.
The  average  Epworth  Sleepiness  Scale  (ESS)  was  sig-
iﬁcantly  lower  in  Group  1  (4.74  ±  0.57)  than  in  Group  2
7.56  ±  0.86)  (p  <  0.01;  95%  CI  −4.86  to  −0.75).  A  negative
orrelation  between  the  average  hours  of  CPAP  use  per  night
nd  ESS  was  observed  (r  =  −0.19;  p  <  0.05)  (Fig.  2).  This  infor-
ation  conﬁrms  that  the  more  the  patient  uses  CPAP  during
he  night,  the  less  he/she  will  present  daytime  sleepiness.
The  type  of  mask  was  not  related  to  compliance  with
PAP  (p  =  0.161,  95%  CI  0.41  to  −1.18).  Importantly,  most
atients  used  nasal  masks  (88.3%  in  Group  1  and  78.7%  in
roup  2),  which  greatly  impaired  the  statistical  comparison
etween  these  two  groups.
Among  the  138  patients,  one  was  using  BiPAP  (with  aver-
ge  usage  of  0  h/night),  4  on  use  of  auto  CPAP  (with  use
verage  of  0.27  ±  0.48),  54  on  use  of  CPAP  with  expiratory
elief  (use  average  of  4.38  ±  0.36)  and  79  in  use  of  basic
PAP  (use  average  of  3.78  ±  0.33).  The  comparison  between
he  latter  two  modes  of  CPAP  (expiratory  relief  and  basic)
as  not  signiﬁcant  (p  =  0.22;  95%  CI  −1.57  to  0.36).
The  ENT  clinical  parameters  (including  tonsil  size,  the
allampati  scale  and  Friedman  scale)  did  not  inﬂuence  the
ompliance  with  CPAP.
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Importance  of  clinical  monitoring  for  compliance  
Discussion
Among  the  different  therapeutic  modalities  for  OSA,  the
positive  impact  of  CPAP  is  clearly  established,  both  for  the
improvement  in  quality  of  life  and  the  positive  effects  on
morbidity  and  mortality  rates.16 Patients  undergoing  treat-
ment  have  healthier  and  more  productive  lives  and  are
less  exposed  to  cardiovascular  risks  and  accidents.  However,
CPAP  efﬁciency  in  improving  sleep  architecture  and  reducing
daytime  drowsiness  is  strongly  inﬂuenced  by  patient  compli-
ance.
In  studies  that  have  deﬁned  adequate  compliance  with
the  use  of  CPAP  as  at  least  4  h  a  night,  compliance  rate
ranged  from  29%  to  83%.17 Consequently,  the  main  obsta-
cles  in  CPAP  treatment  are  directly  related  to  this  factor.  In
a  recent  study,18 it  was  shown  that  the  rate  of  compliance
with  CPAP,  using  these  same  criteria  of  the  present  study,
was  around  65%  among  patients  in  active  follow-up,  a  value
greater  than  that  observed  in  the  current  study.
The  positive  impact  of  CPAP  in  reducing  sleepiness  was
conﬁrmed  in  this  study  by  signiﬁcantly  higher  values  in  ESS  in
maladaptive  patients.  Furthermore,  there  was  a  signiﬁcant
inverse  correlation  between  the  hours  of  CPAP  use  by  night
and  ESS,  that  is,  a  reduction  of  somnolence.  These  results
corroborate  those  described  by  Patel  et  al.19 who,  in  a  meta-
analysis,  showed  that,  compared  to  placebo,  the  treatment
groups  were  able  to  reduce  ESS,  on  average,  2.9  points.
In  our  cohort,  patients  with  depression  had  lower  rates
of  hours  of  use  than  patients  without  depression.  This
result  was  also  suggested  by  Law  et  al.20 No  relation  with
compliance  rate  was  evident  for  other  associated  diseases.
Importantly,  except  for  systemic  hypertension,  other  comor-
bidities  were  not  common,  which  makes  the  statistical
analysis  less  reliable.
It  is  well  established  that  the  diagnosis  of  OSAS  is  most
frequent  in  obese,  male  and  older  individuals.21 On  the  other
hand,  it  is  important  to  identify  which  factors  are  associated
with  compliance  with  CPAP  treatment,  and  which  patient
groups  have  higher  risk  of  quitting  therapy.  This  informa-
tion  is  essential  for  programming  speciﬁc  approaches  to
improve  the  efﬁciency  of  therapy  with  CPAP.  After  evaluat-
ing  4281  patients,  Woehrle  et  al.22 reported  that  compliance
with  CPAP  is  higher  in  older  and  male  patients,  and  con-
cluded  that  the  age  and  gender  inﬂuence  the  compliance
with  treatment,  although  they  did  not  consider  these  data
clinically  relevant.  Moreover,  Budhiraja  et  al.23 and  Queiroz
et  al.18 observed  no  inﬂuence  of  gender  on  treatment
compliance.  In  this  study,  age  and  gender  are  not  statis-
tically  correlated  to  the  compliance  rate.  Regarding  BMI,
in  contrast  with  what  Shapiro  et  al.  mentioned,24 there
was  no  relationship  of  this  parameter  with  compliance
rate.
There  are  no  studies  directly  correlating  the  compli-
ance  rate  to  Mallampati  Scale.  Zonato  et  al.25 demonstrated
a  positive  correlation  between  Mallampati  Scale  and  AHI.
Queiroz  et  al.18 reported  that  a  higher  AHI  at  diagnosis  was
associated  with  higher  compliance  rate,  probably  because
the  most  severe  OSAS  patients  are  more  symptomatic  or
more  concerned  with  the  impact  of  OSAS.  Although  this  asso-
ciation  was  not  observed  in  the  present  study,  we  found  a
direct  (but  of  low  intensity)  correlation  between  the  CPAP
C
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ressure  used  by  the  patient,  and  the  average  number  of
ours  of  use.  This  correlation  suggests  that  patients  with
evere  obstructive  factors  are  more  compliant  with  CPAP
reatment.
Additionally,  the  type  of  mask  (nasal  or  facial)  did  not
ffect  adherence  in  this  cohort;  this  statistical  analysis,
owever,  was  impaired  since  most  of  the  patients  used  nasal
asks.  We  also  did  not  have  any  statistical  difference  of
ours  of  use  among  patients  who  use  basic  CPAP  or  CPAP  with
xpiratory  relief.  These  results  are  in  line  with  those  pre-
ented  by  Bakker  et  al.26 and  Kushida  et  al.,27 but  contradict
he  ﬁndings  of  Chihara  et  al.28
According  to  the  results  of  this  study,  awareness  of  OSAS
nd  its  implications  seems  to  play  a  key  role  in  compliance
ith  CPAP.  This  information  is  important  as  it  stimulates
he  need  to  develop  strategies  to  improve  patients’  per-
eption  of  their  disease  through  educational  programs  for
his  population.  La  Piana  et  al.29 showed  that  educational
rograms  signiﬁcantly  increase  compliance  with  CPAP,  espe-
ially  during  the  ﬁrst  year.  After  this  period,  the  rate  tends
o  decrease.
This  study  suggests  that  regular  and  multidisciplinary
onitoring  after  diagnosis  and  initiation  of  therapy  sig-
iﬁcantly  increases  the  chances  of  compliance  success,
robably  by  facilitating  measures  presented  to  patients,  and
ecause  temporary  problems  could  be  more  easily  resolved
hen  readily  identiﬁed  and  properly  addressed.
Considering  the  type  of  health  system  in  which  the
atient  was  inserted  (Public  or  Private),  there  was  no  sig-
iﬁcant  difference,  although  it  is  known  that  there  is  lower
ompliance  among  patients  of  lower  socioeconomic  status.10
his  ﬁnding  may  be  explained  by  the  program  developed
hrough  the  Agreement  between  HCFMRP  and  Secretaria
unicipal  de  Saúde  de  Ribeirão  Preto,  which  includes  regular
onitoring  of  OSAS  patients  in  a  multidisciplinary  special-
zed  setting.
This  is  a  cross-sectional  cohort  that  did  not  analyze
atients  either  prospectively  or  randomly.  This  made  the
nalysis  of  some  parameters  such  as  the  use  of  the  mask
ot  supportable.  However,  important  information  can  be
btained  from  this  study,  in  particular  on  the  importance
f  continuous  and  systematic  follow-up  of  patients  who  are
sing  CPAP.
onclusion
he  ﬁndings  of  this  study  strongly  support  educational  and
otivational  components  inﬂuencing  compliance  with  CPAP.
hese  aspects  can  be  achieved  by  individualized  and  mul-
idisciplinary  patient  care.  The  importance  of  active  and
egular  monitoring  of  CPAP  users  was  demonstrated,  and  it
s  suggested  that  the  interdisciplinary  approach  facilitates
he  identiﬁcation  of  the  difﬁculties  faced  by  the  patient.
his  continuous  approach  seems  to  considerably  facilitate
ompliance  with  CPAP.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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